Karagas MR - Search Results

1

Placental arsenic concentrations in relation to both maternal and infant biomarkers of exposure in a US cohort.

Punshon T, Davis MA, Marsit CJ, Theiler SK, Baker ER, Jackson BP, Conway DC, Karagas MR. Punshon T, et al. Among authors: karagas mr. J Expo Sci Environ Epidemiol. 2015 Nov-Dec;25(6):599-603. doi: 10.1038/jes.2015.16. Epub 2015 Mar 25. J Expo Sci Environ Epidemiol. 2015. PMID: 25805251 Free PMC article.

2

Toenail samples as an indicator of drinking water arsenic exposure.

Karagas MR, Morris JS, Weiss JE, Spate V, Baskett C, Greenberg ER. Karagas MR, et al. Cancer Epidemiol Biomarkers Prev. 1996 Oct;5(10):849-52. Cancer Epidemiol Biomarkers Prev. 1996. PMID: 8896897

3

Design of an epidemiologic study of drinking water arsenic exposure and skin and bladder cancer risk in a U.S. population.

Karagas MR, Tosteson TD, Blum J, Morris JS, Baron JA, Klaue B. Karagas MR, et al. Environ Health Perspect. 1998 Aug;106 Suppl 4(Suppl 4):1047-50. doi: 10.1289/ehp.98106s41047. Environ Health Perspect. 1998. PMID: 9703491 Free PMC article.

4

Measurement of low levels of arsenic exposure: a comparison of water and toenail concentrations.

Karagas MR, Tosteson TD, Blum J, Klaue B, Weiss JE, Stannard V, Spate V, Morris JS. Karagas MR, et al. Am J Epidemiol. 2000 Jul 1;152(1):84-90. doi: 10.1093/aje/152.1.84. Am J Epidemiol. 2000. PMID: 10901333

5

Skin cancer risk in relation to toenail arsenic concentrations in a US population-based case-control study.

Karagas MR, Stukel TA, Morris JS, Tosteson TD, Weiss JE, Spencer SK, Greenberg ER. Karagas MR, et al. Am J Epidemiol. 2001 Mar 15;153(6):559-65. doi: 10.1093/aje/153.6.559. Am J Epidemiol. 2001. PMID: 11257063

6

Markers of low level arsenic exposure for evaluating human cancer risks in a US population.

Karagas MR, Le CX, Morris S, Blum J, Lu X, Spate V, Carey M, Stannard V, Klaue B, Tosteson TD. Karagas MR, et al. Int J Occup Med Environ Health. 2001;14(2):171-5. Int J Occup Med Environ Health. 2001. PMID: 11548067

7

Assessment of cancer risk and environmental levels of arsenic in New Hampshire.

Karagas MR, Stukel TA, Tosteson TD. Karagas MR, et al. Int J Hyg Environ Health. 2002 Mar;205(1-2):85-94. doi: 10.1078/1438-4639-00133. Int J Hyg Environ Health. 2002. PMID: 12018020

8

Sampling private wells at past homes to estimate arsenic exposure: a methodologic study in New England.

Colt JS, Baris D, Clark SF, Ayotte JD, Ward M, Nuckols JR, Cantor KP, Silverman DT, Karagas M. Colt JS, et al. J Expo Anal Environ Epidemiol. 2002 Sep;12(5):329-34. doi: 10.1038/sj.jea.7500235. J Expo Anal Environ Epidemiol. 2002. PMID: 12198581

9

Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire.

Karagas MR, Tosteson TD, Morris JS, Demidenko E, Mott LA, Heaney J, Schned A. Karagas MR, et al. Cancer Causes Control. 2004 Jun;15(5):465-72. doi: 10.1023/B:CACO.0000036452.55199.a3. Cancer Causes Control. 2004. PMID: 15286466

10

Carcinogen exposure and gene promoter hypermethylation in bladder cancer.

Marsit CJ, Karagas MR, Danaee H, Liu M, Andrew A, Schned A, Nelson HH, Kelsey KT. Marsit CJ, et al. Among authors: karagas mr. Carcinogenesis. 2006 Jan;27(1):112-6. doi: 10.1093/carcin/bgi172. Epub 2005 Jun 29. Carcinogenesis. 2006. PMID: 15987713

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

569 results

Search Page

Filters